Verrica Pharmaceuticals (VRCA) Q4 2023 Earnings

29FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.56
-0.42
-0.27
-0.13

Details

Expected EPS
-0.562
Actual EPS
-0.53
Surprise EPS
0.03
Surprise Percent
+5.69%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.53 per share for Q4 2023.

0 Comments

Share your thoughts